GTC
Ghost Tree Capital’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-98,951
| Closed | -$3.38M | – | 66 |
|
|
2023
Q3 | $3.38M | Sell |
98,951
-86,049
| -47% | -$2.94M | 1.11% | 23 |
|
|
2023
Q2 | $7.12M | Sell |
185,000
-15,000
| -8% | -$578K | 2.35% | 16 |
|
|
2023
Q1 | $7.16M | Buy |
+200,000
| New | +$7.16M | 2.12% | 16 |
|
|
2022
Q2 | – | Sell |
-100,000
| Closed | -$3.06M | – | 42 |
|
|
2022
Q1 | $3.06M | Hold |
100,000
| – | – | 0.66% | 25 |
|
|
2021
Q4 | $3.12M | Sell |
100,000
-690,000
| -87% | -$21.6M | 1.12% | 34 |
|
|
2021
Q3 | $12.1M | Sell |
790,000
-60,000
| -7% | -$917K | 3.53% | 6 |
|
|
2021
Q2 | $15.8M | Hold |
850,000
| – | – | 4.35% | 4 |
|
|
2021
Q1 | $15.2M | Buy |
850,000
+150,000
| +21% | +$2.69M | 3.58% | 7 |
|
|
2020
Q4 | $10.8M | Buy |
700,000
+375,000
| +115% | +$5.77M | 2.4% | 17 |
|
|
2020
Q3 | $3.6M | Hold |
325,000
| – | – | 1.04% | 29 |
|
|
2020
Q2 | $4.08M | Hold |
325,000
| – | – | 1.08% | 28 |
|
|
2020
Q1 | $3.69M | Buy |
+325,000
| New | +$3.69M | 0.98% | 20 |
|
|
2017
Q2 | – | Sell |
-150,000
| Closed | -$600K | – | 70 |
|
|
2017
Q1 | $600K | Sell |
150,000
-175,000
| -54% | -$700K | 0.11% | 55 |
|
|
2016
Q4 | $2.5M | Hold |
325,000
| – | – | 0.6% | 45 |
|
|
2016
Q3 | $2.63M | Buy |
+325,000
| New | +$2.63M | 0.43% | 45 |
|
|
2015
Q3 | – | Sell |
-37,500
| Closed | -$432K | – | 88 |
|
|
2015
Q2 | $432K | Buy |
+37,500
| New | +$432K | 0.14% | 63 |
|